Geron Corp (NAS:GERN)
$ 4.54 0.06 (1.34%) Market Cap: 2.74 Bil Enterprise Value: 2.46 Bil PE Ratio: 0 PB Ratio: 8.90 GF Score: 35/100

Geron Corporation - Special Call Transcript

Jun 17, 2020 / 12:00PM GMT
Release Date Price: $1.75 (+3.55%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to Geron's Key Opinion Leader Conference Call. (Operator Instructions) I would now like to hand the conference over to your moderator for today, Suzanne Messere, Head of Investor Relations. Ms. Messere, please go ahead.

Suzanne Messere
Geron Corporation - Head of IR & Corporate Communications

Thanks, Jack. Welcome to Geron's KOL event to discuss recent data presented at the virtual edition of the 25th Annual European Hematology Annual Congress.

I am joined today by Geron's Chief Medical Officer, Dr. Aleksandra Rizo; Dr. Valeria Santini; Dr. John Mascarenhas; Dr. Rami Komrokji; and Geron's Chairman and CEO, Dr. John Scarlett. Before we begin, please note that this presentation and question-and-answer session will contain forward-looking statements relating to Geron's plans, expectations, time lines, beliefs, statements of potentiality and projections. These include, without limitation, those regarding that imetelstat has potential disease-modifying activity and that Geron has a plan to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot